Page last updated: 2024-12-05

simazine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Simazine is a triazine herbicide that was first synthesized in 1955 by Ciba-Geigy. It acts by inhibiting photosynthesis in plants, specifically by blocking the electron transport chain in photosystem II. Simazine is commonly used to control weeds in a variety of crops, including corn, soybeans, and cotton. It is also used on turfgrass and in forestry. Simazine can be absorbed through the roots, leaves, and stems of plants, making it an effective herbicide. Due to its persistent nature, it can persist in the soil and water for extended periods, potentially impacting aquatic life and ecosystems. Therefore, simazine has been subject to significant research and regulation, with its use being restricted in some countries due to its potential environmental and health concerns. Simazine is known to be toxic to aquatic organisms and can accumulate in the food chain. It has also been associated with various health effects, including skin and eye irritation, respiratory problems, and potential carcinogenic properties. Its persistence in the environment and potential health risks have prompted studies to explore alternative herbicides and sustainable practices to minimize its impact.'

Simazine: A triazine herbicide. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

simazine : A diamino-1,3,5-triazine that is N,N'-diethyl-1,3,5-triazine-2,4-diamine substituted by a chloro group at position 6. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5216
CHEMBL ID1605837
CHEBI ID27496
SCHEMBL ID37774
MeSH IDM0019881

Synonyms (183)

Synonym
BIDD:ER0337
AC-12676
BRD-K01416914-001-02-3
6-chloro-n(2),n(4)-diethyl-1,3,5-triazine-2,4-diamine
2-chloro-4,6-bis(ethylamino)-1,3,5-triazine
2,4-bis(ethylamino)-6-chloro-1,3,5-triazine
6-chloro-n,n'-diethyl-1,3,5-triazine-2,4-diamine
6-chloro-n,n'-diethyl-[1,3,5]triazin-2,4-diamine
CHEBI:27496 ,
bitemol s-50
2,4-bis(ethylamino)-6-chloro-s-triazine
g-27692
hungazin dt
batazina
premazine
princep
gesaran
gesapun
herbazin
printop
taphazine
2-chloro-4,6-bis(ethylamino)-s-triazine
primatel s
gesatop
aktinit s
gesatop 50
h 1803
herbazin 50
aquazine
1,5-triazine-2,4-diamine, 6-chloro-n,n'-diethyl-
radokor
tafazine 50-w
w 6658
symazine
s-triazine,6-bis(ethylamino)-
cekuzina-s
primatol s
a 2079
1-chloro-3,4,6-triazine
bitemol
simadex
cat (herbicide)
herbex
radocon
zeapur
simazine 80w
g 27692
simanex
wln: t6n cn enj bm2 dm2 fg
triazine a 384
simazin
tafazine
amizine
geigy 27,692
herboxy
nsc25999
gesatop-50
nsc-25999
DIVK1C_006496
ENAMINE_005673
KBIO1_001440
2,4-diamine-6-chloro-n,n'-diethyl-1,3,5-triazine
2-chloro-4,6-bis(ethylamino)triazine
aquazine 90wdg
caliber 90
princep 80w
printrex
6-chloro-n,n'-diethyl-1,3,5-triazine-2,4-diyldiamine
princep caliber 90
princep 4l
sim-trol 4l
1-chloro-3,5-bisethylamino-2,4,6-triazine
cekusan gesatop
bitemol s 50
cekuzinas
princep 4g
chloro-4,6-bis( ethylamino)-s-triazine
framed
permazine
6-chloro-n,n'-diethyl-2,4-diaminetriazine
simazat
SPECTRUM_001809
SPECTRUM5_001950
s-triazine, 2-chloro-4,6-bis(ethylamino)-
1,3,5-triazine-2,4-diamine, 6-chloro-n,n'-diethyl-
OPREA1_871264
brn 0010895
1-chloro-3,5-bis(ethylamino)-2,4,6-triazine
azotop
tafazine (van)
simazine [ansi:bsi:iso]
herbatoxol s
yrodazin
herbex (pesticide)
cekusima
2,4-bis(aethylamino)-6-chlor-1,3,5-triazin [german]
simatsin-neste
nsc 25999
ai3-51142
epa pesticide chemical code 080807
hsdb 1765
batazine flo
einecs 204-535-2
caswell no. 740
ccris 1469
6-chloro-n2,n4-diethyl-1,3,5-triazine-2,4-diamine
122-34-9
simazine
simazine, analytical standard
BSPBIO_002319
NCGC00094524-03
NCGC00094524-01
NCGC00094524-02
KBIO3_001819
KBIOSS_002302
KBIOGR_001039
KBIO2_004868
KBIO2_007436
KBIO2_002300
SPECPLUS_000400
SPECTRUM2_001879
SPECTRUM3_000820
SPECTRUM4_000660
SPBIO_001758
SPECTRUM330028
IDI1_007908
NCGC00094524-05
NCGC00094524-04
herbazin-50
STK386441
6-chloro-2-n,4-n-diethyl-1,3,5-triazine-2,4-diamine
AKOS003629500
NCGC00094524-06
NCGC00094524-07
1,3,5-triazine-2,4-diamine, 6-chloro-n2,n4-diethyl-
sg0c34smy3 ,
unii-sg0c34smy3
2,4-bis(aethylamino)-6-chlor-1,3,5-triazin
tox21_300748
tox21_202378
NCGC00259927-01
NCGC00254653-01
CHEMBL1605837
dtxsid4021268 ,
tox21_111291
cas-122-34-9
dtxcid501268
CCG-39417
[6-chloro-4-(ethylamino)(1,3,5-triazin-2-yl)]ethylamine
FT-0603326
SCHEMBL37774
NCGC00094524-09
tox21_111291_1
KS-5070
simazine [iarc]
simazine [hsdb]
6-chloro-n(sup 2),n(sup 4)-diethyl-1,3,5-triazine-2,4-diamine
simazine [mi]
simazine [iso]
n,n'-diethyl-6-chloro-[1,3,5]triazine-2,4-diamine
2-chloro-4,6-bis-ethylamino-1,3,5-triazine
2,4-di(ethylamino)-6-chloro-1,3,5-triazine
triazine a384
s-triazine, 2,4-bis(ethylamino)-6-chloro-
simazine 50
4,6-bis(ethylamino)-2-chlorotriazine
simatox
2-chloro-4,6-di(ethylamino)triazine
mfcd00023174
J-004790
simazine, pestanal(r), analytical standard
simazine 10 microg/ml in ethyl acetate
simazine 100 microg/ml in acetonitrile
simazine 10 microg/ml in acetonitrile
herboxydiene
imazine
Q416160
simazine 100 microg/ml in acetone
CS-0014141
HY-B2046
H10514
I1146
simazin solution

Research Excerpts

Overview

Simazine is a suspected endocrine disruptor and the second most commonly detected pesticide in surface and groundwater worldwide. Simazine is an s-triazine herbicide world widely used for the control of broadleaf weeds.

ExcerptReferenceRelevance
"Simazine is a widely used herbicide and known as an environmental estrogen. "( Autonomic behavioral impairment induced by simazine exposure during early life of male mouse is mediated by Lmx1a/Wnt1 pathway.
Hu, X; Jiang, Y; Li, B; Li, X; Wang, D; Wang, T, 2022
)
2.43
"Simazine is a kind of persistent organic pollutant that is detected in both ground and water and has several routes of exposure. "( Injury to dopaminergic neurons development via the Lmx1a/Wnt1 autoregulatory loop induced by simazine.
Jiang, Y; Li, B; Li, J; Li, P; Li, X; Wu, Y, 2020
)
2.22
"Simazine is an herbicide that is able to contaminate surface waters, ground waters, and milk/dairy products, thus posing concerns in both environmental health and food safety. "( Towards Simazine Monitoring in Agro-Zootechnical Productions: A Yeast Cell Bioprobe for Real Samples Screening.
Caracciolo, L; Cocco, G; Dragone, R; Frazzoli, C; Grasso, G, 2018
)
2.36
"Simazine is a suspected endocrine disruptor and the second most commonly detected pesticide in surface and groundwater worldwide. "( Impaired development of female mouse offspring maternally exposed to simazine.
Bae, J; Jin, H; Kim, S; Lee, K; Park, S, 2014
)
2.08
"Simazine is a s-triazine herbicide that has been applied worldwide for agriculture. "( Adsorption studies of the herbicide simazine in agricultural soils of the Aconcagua valley, central Chile.
Flores, C; González, M; Morgante, V; Navia, R; Seeger, M, 2009
)
2.07
"Simazine is an s-triazine herbicide world widely used for the control of broadleaf weeds. "( Influence of microorganisms and leaching on simazine attenuation in an agricultural soil.
Cereceda-Balic, F; Fadic, X; Flores, C; González, M; Hernández, M; Morgante, V; Seeger, M, 2012
)
2.08
"Simazine is a triazine herbicide which has been used for a long period in agriculture and in the aquatic environment for control of weeds and algae. "( Effects of subchronic exposure to simazine on zebrafish (Danio rerio).
Bedanova, I; Dolezelova, P; Haluzova, I; Macova, S; Marsalek, P; Pistekova, V; Plhalova, L; Praskova, E; Skoric, M; Svobodova, Z, 2011
)
2.09
"Simazine is a triazine herbicide that is being widely applied worldwide and commonly detected in surface and groundwater. "( Disturbed relaxin signaling pathway and testicular dysfunction in mouse offspring upon maternal exposure to simazine.
Bae, J; Park, HO, 2012
)
2.03
"Simazine is a soil-active herbicide that has been applied worldwide in agricultural soils, being the second most commonly detected herbicide in groundwater and surface waters. "( Simazine transport in undisturbed soils from a vineyard at the Casablanca valley, Chile.
Alister, C; Bachmann, J; Guzmán, E; Kogan, M; Muñoz, JF; Ortiz, C; Suárez, F, 2013
)
3.28
"Simazine is a triazine herbicide used in agriculture, pot-plant and tree production. "( Field effects of simazine at lower trophic levels--a review.
Scott-Fordsmand, JJ; Strandberg, MT, 2002
)
2.1

Effects

ExcerptReferenceRelevance
"Simazine and NaNO2 have been studied for their effect on cytochrome P-450-binding N-demethylation and denitrosation activity in the rat liver and lymphocytes in the subchronic (two-month-long) experiment. "( [N-demethylation and denitrosation activity of the rat liver, thymus lymphocytes and spleen after exposure to simazine and sodium nitrite].
Dmitrenko, NP; Snoz, SV,
)
1.79

Actions

ExcerptReferenceRelevance
"Simazine can inhibit the cellular immune function and the humoral immune function."( [Immunotoxic effect of herbicide simazine exposure in BALB/c mice].
Ren, R; Wang, MQ; Zhang, Y; Zheng, J, 2009
)
2.08

Treatment

Simazine treatment (600 mg/kg) induced an increase in the percentage of CD4(+) cells in spleen and CD8 + in thymus. Simazine or starvation treatment independently activated the lizard HPA axis, but co-treatment caused the HPAaxis inhibition.

ExcerptReferenceRelevance
"Simazine or starvation treatment independently activated the lizard HPA axis, but co-treatment caused the HPA axis inhibition."( Effects of simazine and food deprivation chronic stress on energy allocation among the costly physiological processes of male lizards (Eremias argus).
Diao, J; Wang, Z; Xu, Y; Yu, S; Zhang, L; Zhou, Z; Zhu, W, 2021
)
1.73
"Simazine-treated corn area was computed as the total simazine load (g) divided by total atrazine load (g ha"( Estimating simazine-treated area in watersheds based on annual stream loads.
Lerch, RN; Willett, CD, 2021
)
1.73
"Simazine treatment (600 mg/kg) induced an increase in the percentage of CD4(+) cells in spleen and CD8 + in thymus."( Immune alterations in mice exposed to the herbicide simazine.
Hee-Um, S; Kim, BO; Kim, KR; Pyo, S; Rhee, DK; Son, EW, 2003
)
1.29

Toxicity

The authors investigated the toxic effects of simazine on mice spleen immune cells and the underlying mechanisms. Algal cell recovery from simazine toxic effect occurred after 2 and 4 days for Anabaena and Protosiphon, respectively.

ExcerptReferenceRelevance
" Algal cell recovery from simazine toxic effect occurred after 2 and 4 days for Anabaena and Protosiphon, respectively, which may be attributed to the difference in algal genotype of the tested organisms."( Chlorophyll a fluorescence and photosynthetic activity as tools for the evaluation of simazine toxicity to Protosiphon botryoides and Anabaena variabilis.
Battah, MG; Eladel, HM; Kobbia, IA; Shabana, EF, 2001
)
0.83
" Acetochlor and its photolytic degradation products were found to be more toxic to bacteria than fungi."( Microbial toxicity of pesticide derivatives produced with UV-photodegradation.
Kiss, A; Naár, Z; Virág, D, 2007
)
0.34
"The authors investigated the toxic effects of simazine on mice spleen immune cells and the underlying mechanisms."( Oral exposure to the herbicide simazine induces mouse spleen immunotoxicity and immune cell apoptosis.
Ren, R; Sun, DJ; Wu, YP; Yan, H; Zhang, Y, 2013
)
0.93
" Genotoxicity tests showed that formulations of nanocapsules containing the herbicides were less toxic than the free herbicides."( Poly(ε-caprolactone)nanocapsules as carrier systems for herbicides: physico-chemical characterization and genotoxicity evaluation.
de Lima, R; dos Santos, NZ; Fraceto, LF; Grillo, R; Maruyama, CR; Rosa, AH, 2012
)
0.38
" Both loaded and unloaded NC_PCL were the most toxic formulations to developmental rate, significantly reducing worms length, even at low concentrations."( Safety assessment of nanopesticides using the roundworm Caenorhabditis elegans.
Ávila, DS; Campos, EV; Fraceto, LF; Jacques, MT; Oliveira, JL, 2017
)
0.46

Compound-Compound Interactions

ExcerptReferenceRelevance
"Continuous flow microextraction (CFME) combined with high-performance liquid chromatography-ultraviolet (HPLC-UV) detection has been applied to the analysis of five widely used pesticides, simazine, fensulfothion, etridiazole, mepronil and bensulide, present at trace levels in water samples."( Continuous flow microextraction combined with high-performance liquid chromatography for the analysis of pesticides in natural waters.
He, Y; Lee, HK, 2006
)
0.52

Bioavailability

ExcerptReferenceRelevance
" However, pesticide bioavailability in aged soils has been characterized by a variety of methods with limited success, due in part to methodological limitations."( Influence of soil aging on sorption and bioavailability of simazine.
Koskinen, WC; Regitano, JB; Sadowsky, MJ, 2006
)
0.58
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" Based on dosage mortality curves obtained with increasing amounts of atrazine, mortalities of 50 percent of the insect populations would have been achieved with 23, 40, 6, and 10 micrograms of atrazine added to the abovementioned dosages of carbofuran, DDT, parathion, and diazinon, respectively."( Synergism of insecticides by herbicides.
Anderegg, BN; Liang, TT; Lichtenstein, EP, 1973
)
0.25
" Animals that were dosed with 50, 150, or 300 mg/kg of atrazine or simazine alone for 3 consecutive days did not exhibit any significant increases in uterine wet weight while decreases in cytosolic progesterone receptor (PR) binding levels and uterine peroxidase activity were observed."( Failure of chloro-S-triazine-derived compounds to induce estrogen receptor-mediated responses in vivo and in vitro.
Berhane, K; Chen, I; Connor, K; Howell, J; Liu, H; Safe, S; Sciarretta, C; Zacharewski, T, 1996
)
0.53
" However, for the pulse PAC addition mode, the model predicted somewhat lower effluent SOC concentration than the observed values, and the benefit of pulse PAC application in terms of reducing SOC over its continuous dosage was not confirmed."( Removal of a synthetic organic chemical by PAC-UF systems. II: Model application.
Colas, F; Matsui, Y; Yuasa, A, 2001
)
0.31
" There was no evidence of a dose-response relationship between triazines and ovarian cancer (P=0."( Triazine herbicides and epithelial ovarian cancer risk in central California.
Cress, RD; Mills, PK; Riordan, DG; Young, HA, 2005
)
0.33
" Here we developed and applied a new protocol allowing dose-response assessment of four samples within 2 h (8 dilutions in duplicate)."( Rapid exposure assessment of PSII herbicides in surface water using a novel chlorophyll a fluorescence imaging assay.
Bengtson Nash, SM; Escher, BI; Mueller, JF; Muller, R; Quayle, P; Schreiber, U, 2008
)
0.35
"1% by O3H2O2 system when the O3 was dosed as 10."( [Degradation of simazine by O3/H2O2 system].
Li, SF; Shi, Y; Zhang, RQ, 2008
)
0.69
" The extended dosing period after VO provides a sufficient time period to monitor the effects of a toxicant on estrous cyclicity, an important measure for reproductive competence."( The effects of simazine, a chlorotriazine herbicide, on pubertal development in the female Wistar rat.
Gibson, EK; Stoker, TE; Zorrilla, LM, 2010
)
0.71
" Water samples were collected from the wetland upstream of the dosing system at 3 h intervals from the beginning through 360 h and at the exit point at 1, 2, and 3 h intervals for the periods of 0-24, 25-48 and 49-360 h after dosing, respectively."( Norflurazon and simazine removal from surface water using a constructed wetland.
Lin, Y; Lu, H; Wilson, PC, 2011
)
0.72
" The effect of several experimental parameters such as pH, contact time, initial concentration and sorbent dosage on the sorption of the herbicide was investigated."( Decontamination of waters polluted with simazine by sorption on mesoporous metal oxides.
Addorisio, V; Esposito, S; Pirozzi, D; Sannino, F, 2011
)
0.64
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
herbicideA substance used to destroy plant pests.
xenobioticA xenobiotic (Greek, xenos "foreign"; bios "life") is a compound that is foreign to a living organism. Principal xenobiotics include: drugs, carcinogens and various compounds that have been introduced into the environment by artificial means.
environmental contaminantAny minor or unwanted substance introduced into the environment that can have undesired effects.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
chloro-1,3,5-triazineA member of the class of 1,3,5-triazines that is 1,3,5-triazine substituted by at least one chloro group at unspecified position.
diamino-1,3,5-triazineAny member of the class of 1,3,5-triazines that consists of a 1,3,5-triazine skeleton substituted by two amino groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
deethylsimazine degradation19

Protein Targets (21)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency31.86080.002541.796015,848.9004AID1347395
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency55.18983.189029.884159.4836AID1224846
RAR-related orphan receptor gammaMus musculus (house mouse)Potency48.75530.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency2.47430.000714.592883.7951AID1259369; AID1259392
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency58.56510.000657.913322,387.1992AID1259377
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency27.41710.001022.650876.6163AID1224838
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency25.12520.003041.611522,387.1992AID1159552; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency8.54670.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency21.55770.001530.607315,848.9004AID1224848; AID1224849
pregnane X nuclear receptorHomo sapiens (human)Potency30.76250.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency1.72700.000229.305416,493.5996AID743075
GVesicular stomatitis virusPotency2.75400.01238.964839.8107AID1645842
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency61.92400.001019.414170.9645AID743191
aryl hydrocarbon receptorHomo sapiens (human)Potency76.48950.000723.06741,258.9301AID743085
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency39.81070.00798.23321,122.0200AID2551
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency28.18380.251215.843239.8107AID504327
lamin isoform A-delta10Homo sapiens (human)Potency0.00220.891312.067628.1838AID1487
Interferon betaHomo sapiens (human)Potency2.75400.00339.158239.8107AID1645842
HLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)Potency2.75400.01238.964839.8107AID1645842
Inositol hexakisphosphate kinase 1Homo sapiens (human)Potency2.75400.01238.964839.8107AID1645842
cytochrome P450 2C9, partialHomo sapiens (human)Potency2.75400.01238.964839.8107AID1645842
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (45)

Processvia Protein(s)Taxonomy
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell activation involved in immune responseInterferon betaHomo sapiens (human)
cell surface receptor signaling pathwayInterferon betaHomo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to virusInterferon betaHomo sapiens (human)
positive regulation of autophagyInterferon betaHomo sapiens (human)
cytokine-mediated signaling pathwayInterferon betaHomo sapiens (human)
natural killer cell activationInterferon betaHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylation of STAT proteinInterferon betaHomo sapiens (human)
cellular response to interferon-betaInterferon betaHomo sapiens (human)
B cell proliferationInterferon betaHomo sapiens (human)
negative regulation of viral genome replicationInterferon betaHomo sapiens (human)
innate immune responseInterferon betaHomo sapiens (human)
positive regulation of innate immune responseInterferon betaHomo sapiens (human)
regulation of MHC class I biosynthetic processInterferon betaHomo sapiens (human)
negative regulation of T cell differentiationInterferon betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterferon betaHomo sapiens (human)
defense response to virusInterferon betaHomo sapiens (human)
type I interferon-mediated signaling pathwayInterferon betaHomo sapiens (human)
neuron cellular homeostasisInterferon betaHomo sapiens (human)
cellular response to exogenous dsRNAInterferon betaHomo sapiens (human)
cellular response to virusInterferon betaHomo sapiens (human)
negative regulation of Lewy body formationInterferon betaHomo sapiens (human)
negative regulation of T-helper 2 cell cytokine productionInterferon betaHomo sapiens (human)
positive regulation of apoptotic signaling pathwayInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell differentiationInterferon betaHomo sapiens (human)
natural killer cell activation involved in immune responseInterferon betaHomo sapiens (human)
adaptive immune responseInterferon betaHomo sapiens (human)
T cell activation involved in immune responseInterferon betaHomo sapiens (human)
humoral immune responseInterferon betaHomo sapiens (human)
positive regulation of T cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
adaptive immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independentHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of T cell anergyHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
defense responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
detection of bacteriumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-12 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-6 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protection from natural killer cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
innate immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of dendritic cell differentiationHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class IbHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
inositol phosphate metabolic processInositol hexakisphosphate kinase 1Homo sapiens (human)
phosphatidylinositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
negative regulation of cold-induced thermogenesisInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (18)

Processvia Protein(s)Taxonomy
cytokine activityInterferon betaHomo sapiens (human)
cytokine receptor bindingInterferon betaHomo sapiens (human)
type I interferon receptor bindingInterferon betaHomo sapiens (human)
protein bindingInterferon betaHomo sapiens (human)
chloramphenicol O-acetyltransferase activityInterferon betaHomo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
signaling receptor bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
peptide antigen bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein-folding chaperone bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
inositol-1,3,4,5,6-pentakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol heptakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
protein bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
ATP bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 1-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 3-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol 5-diphosphate pentakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol diphosphate tetrakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (22)

Processvia Protein(s)Taxonomy
extracellular spaceInterferon betaHomo sapiens (human)
extracellular regionInterferon betaHomo sapiens (human)
Golgi membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
endoplasmic reticulumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
Golgi apparatusHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
cell surfaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
ER to Golgi transport vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
secretory granule membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
phagocytic vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
early endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
recycling endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular exosomeHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
lumenal side of endoplasmic reticulum membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
MHC class I protein complexHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular spaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
external side of plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
fibrillar centerInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
cytosolInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleusInositol hexakisphosphate kinase 1Homo sapiens (human)
cytoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (38)

Assay IDTitleYearJournalArticle
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1347424RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347425Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347407qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (357)

TimeframeStudies, This Drug (%)All Drugs %
pre-199063 (17.65)18.7374
1990's36 (10.08)18.2507
2000's137 (38.38)29.6817
2010's92 (25.77)24.3611
2020's29 (8.12)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.34 (24.57)
Research Supply Index5.98 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index96.86 (26.88)
Search Engine Supply Index3.73 (0.95)

This Compound (35.34)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews8 (2.04%)6.00%
Case Studies1 (0.25%)4.05%
Observational0 (0.00%)0.25%
Other384 (97.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]